22-Apr-2024
No headlines found.
No press releases found.
No news found.
BTAL's objective is to provide a consistent negative beta exposure to the U.S. equity market. BTAL strives to achieve this objective by investing primarily in long positions in low beta U.S. equities and short positions in high beta U.S. equities on a dollar neutral basis, within sectors. The investment objective and Principal Investment Strategies of the AGFiQ U.S. Market Neutral Anti-Beta Fund were changed on February 14, 2022. It dopped Dow Jones U.S. Thematic Market Neutral Low Beta Index, to become actively managed.
Agfiq US Market Neutral Anti-Beta trades on the ARCA stock market under the symbol BTAL.
As of April 22, 2024, BTAL stock price declined to $19.14 with 476,193 million shares trading.
BTAL has a beta of -0.84, meaning it tends to be less sensitive to market movements. BTAL has a correlation of 0.35 to the broad based SPY ETF.
BTAL has a market cap of $258.39 million. This is considered a Small Cap stock.
In the last 3 years, BTAL stock traded as high as $22.04 and as low as $16.15.
BTAL stock has underperformed the market in the last year with a return of -2.2%, while SPY returned +22.3%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in BTAL shares. However, BTAL has outperformed the market in the last 3 month and 2 week periods, returning +5.2% and +3.2%, while SPY returned +3.9% and -3.6%, respectively. This indicates BTAL has been having a stronger performance recently.
BTAL support price is $19.06 and resistance is $19.46 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BTAL stock will trade within this expected range on the day.